LYTIR

Company · BBIO

BridgeBio Pharma, Inc.

Nasdaq's symbol directory lists BBIO on Nasdaq as “BridgeBio Pharma, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 12 occasions ($28.4M); 4 filings by holders of 5% or more; 6 congressional trade disclosures; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $28.4M in total.Jun: Insider sales $9.1MJul: Insider sales $14.8MAug: Insider sales $3.7MSep: Insider sales $691KOct: Insider sales $146KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $28.4M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Jennifer E. Cook sold on 4 days all under a 10b5-1 plan latest Jul 9, 2026 sold $21.9M
  2. Kumar Neil, Chief Executive Officer sold on 3 days all under a 10b5-1 plan latest Sep 17, 2026 sold $4.4M
  3. Ellis Andrea sold on 1 day all under a 10b5-1 plan latest Jul 9, 2026 sold $1.4M
  4. Valantine Hannah sold on 2 days all under a 10b5-1 plan latest Jun 23, 2026 sold $342K
  5. Apuli Maricel, Chief Accounting Officer sold on 2 days all under a 10b5-1 plan latest Oct 30, 2026 sold $306K
Every trade (12)
  1. SELLApuli Maricel, Chief Accounting Officer sold Oct 30, 2026 2,000 shares 10b5-1 plan (scheduled) filing $146K
  2. SELLKumar Neil, Chief Executive Officer sold Sep 17, 2026 10,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $691K
  3. SELLKumar Neil, Chief Executive Officer sold Aug 19, 2026 10,000 shares 3 legs combined 10b5-1 plan (scheduled) filing $840K
  4. SELLKumar Neil, Chief Executive Officer sold Aug 18, 2026 34,980 shares 4 legs combined 10b5-1 plan (scheduled) filing $2.9M
  5. SELLApuli Maricel, Chief Accounting Officer sold Jul 30, 2026 2,000 shares 10b5-1 plan (scheduled) filing $160K
  6. SELLJennifer E. Cook sold Jul 9, 2026 148,589 shares 2 legs combined 10b5-1 plan (scheduled) filing $13.2M
  7. SELLEllis Andrea sold Jul 9, 2026 17,167 shares 10b5-1 plan (scheduled) filing $1.4M
  8. SELLJennifer E. Cook sold Jun 24, 2026 37,167 shares 10b5-1 plan (scheduled) filing $2.6M
  9. SELLJennifer E. Cook sold Jun 23, 2026 2,196 shares 10b5-1 plan (scheduled) filing $151K
  10. SELLValantine Hannah sold Jun 23, 2026 2,196 shares 10b5-1 plan (scheduled) filing $151K
  11. SELLValantine Hannah sold Jun 22, 2026 2,808 shares 10b5-1 plan (scheduled) filing $191K
  12. SELLJennifer E. Cook sold Jun 15, 2026 90,240 shares 2 legs combined 10b5-1 plan (scheduled) filing $6.0M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. BlackRock, Inc. filed Oct 27, 2026 Schedule 13G passive 9,892,226 shares filing 5.1%
  2. KKR Genetic Disorder L.P. filed Aug 17, 2026 Schedule 13D/A may seek influence 8,260,971 shares filing 4.2%
  3. Farallon Capital Management, L.L.C. filed Aug 3, 2026 Schedule 13G/A passive filing 5.5%
  4. VIKING GLOBAL INVESTORS LP filed Jul 10, 2026 Schedule 13D/A may seek influence 9,792,219 shares filing 5%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Gilbert Cisneros (D-CA31): Sale Sep 29, 2026 reported Oct 12, 2026 one of 57 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  2. Gilbert Cisneros (D-CA31): Purchase May 11, 2026 reported Jun 8, 2026 one of 103 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  3. Gilbert Cisneros (D-CA31): Purchase Apr 29, 2026 reported May 8, 2026 one of 94 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  4. Gilbert Cisneros (D-CA31): Purchase Mar 19, 2026 reported Apr 7, 2026 one of 141 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  5. Gilbert Cisneros (D-CA31): Purchase Mar 18, 2026 reported Apr 7, 2026 one of 141 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  6. Gilbert Cisneros (D-CA31): Purchase Mar 3, 2026 reported Apr 7, 2026 one of 141 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Oct 29, 2026
  2. Other events filing Oct 13, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.